Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review

Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review

Yanchun Qu,1– 3,* Yufeng Liu,3,* Kailin Ding,3 Yong Li,1,2 Xiaoyu Hong,4 Haibo Zhang1,2 1Department of Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Department of Oncology, Guangdong Provincial Hospit...

Full description

Bibliographic Details
Main Authors: Qu Y, Liu Y, Ding K, Li Y, Hong X, Zhang H
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:OncoTargets and Therapy
Subjects:
breast cancer
her2 amplification
her2 r157w mutation
pyrotinib plus capecitabine
anti-her2 treatment
Online Access:https://www.dovepress.com/partial-response-to-pyrotinib-plus-capecitabine-in-an-advanced-breast--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/partial-response-to-pyrotinib-plus-capecitabine-in-an-advanced-breast--peer-reviewed-article-OTT

Similar Items